个人简述:

- Bao-cheng Liu, Guang Ji. Sparking Thinking: Studying Modern Precision Medicine Will Accelerate the Progression of Traditional Chinese Medicine Patterns. J Altern Complement Med. 2017 Apr 24

- Bao-cheng Liu, et al . Pharmacogenomics in schizophrenia: HTR2C promoter polymorphisms are associated with risperidone efficacy in Chinese female patients. Pharmacogenomics. (2010)11(5), 685-692

ž -Bao-cheng Liu,et al . No association between EGR gene family polymorphisms and schizophrenia in the Chinese population. Progress in Neuropsycho pharmacology& Biological Psychiatry.2010; 34(3):506-9.

ž -Bao-cheng Liu, et al. A cross-national comparative study of orphan drug policies in the United States, the European Union and Japan: Towards a made-in-China orphan drug policy.Journal of Public Health Policy. 2010 Vol. 31, 4, 407–421

ž -Qing-zhu Zhao*, Bao-cheng Liu* et. al. Association between COMT polymorphism and clinical response to risperidone treatment: A pharmacogenetic study. Psychiatr Genet. 2012 Dec;22(6):298-9

ž -Xing-wang Li*, Bao-cheng Liu*, Yang Wang, Qing-zhuZha,Qi shen, Shiqing Chen, JueJi, Feng-ping Yang, Ling-hanGao, Yi-fengXu,Guo-yin Feng, Lin He, Guang He. NAPG is not a common risk gene for Bipolar Disorder and schizophrenia.PsychiatrGenet. 2012Apr;22(2):107-8.

ž -Bao-cheng Liu, et al.Translational medicine in China: a long hopeful way with hurdles. (Chinese version) Int J Genet. Jun, 2010, Vol.33, No.3

ž -Bao-cheng Liu, Guang He, and Lin He.Frontier genomics study progress in Schizophrenia. (Chinese version) Int J Genet. Dec, 2010, Vol.33, No.6

科研工作:

中华中医药学会健康管理分会 委员

上海市医学会肝病专科分会 青年委员

序号课题名称研究起止时间经费数(万元)备注81603411《非酒精性脂肪肝脾阳虚证与易感基因、危险因素的相关性研究》

2017年1月-2019年12月

18国家自然基金ZYKC201601011《基于互联网医疗的糖尿病中医干预管理平台开发与研究》2016年10月-2019年10月7上海市中医药科技创新项目2015YSN19《高血压前期 RAAS 通路基因、环境和中医症候的关联性研究》2016年1月-2017年12月5上海中医药大学校内预算科研项目

教育背景:

2007.09-2012.11上海交通大学 理学博士

2011.01-2012.01美国密西根大学医学院 访问学者

2009.07-2009.08北京大学医学部公共卫生学院暑期学校